Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic

  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Longeveron Inc (NQ: LGVN )

2.070 -0.010 (-0.48%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Longeveron Inc

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Mid-Afternoon Market Update: Dow Falls 200 Points; Connect Biopharma Shares Tumble
Toward the end of trading Friday, the Dow traded down 0.58% to 35,664.58 while the NASDAQ rose 0.53% to 16,078.19. The S&P also rose, gaining 0.05% to 4,706.69. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
Benchmarks Mixed as Dow Heads for Weekly, Daily Drop
Stocks are mixed midday, as Wall Street warily eyes the resurgence of Covid-19 cases internationally. 
Via Talk Markets
Topics Stocks
Exposures COVID-19 US Equities
Mid-Day Market Update: Crude Oil Down Over 4%; UWM Holdings Shares Surge
Midway through trading Friday, the Dow traded down 0.62% to 35,648.81 while the NASDAQ rose 0.53% to 16,078.23. The S&P also fell, dropping 0.01% to 4,704.35. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
33 Stocks Moving In Friday's Mid-Day Session
Gainers Greenland Technologies Holding Corporation (NASDAQ: GTEC) shares jumped 75.4% to $9.17. Greenland Technologies highlighted the launch of second electric industrial... 
Via Benzinga
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Exposures Product Safety
Mid-Morning Market Update: Markets Mixed; Foot Locker Profit Beats Views
Following the market opening Friday, the Dow traded down 0.66% to 35,634.40 while the NASDAQ rose 0.54% to 16,079.51. The S&P also fell, dropping 0.03% to 4,703.27. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Good morning, trader! We're starting off the final day of trading this week with a look at the biggest pre-market stock movers for Friday! 
Via InvestorPlace
20 Stocks Moving in Friday's Pre-Market Session
Gainers Mammoth Energy Services, Inc. (NASDAQ: TUSK) rose 29.9% to $2.87 in pre-market trading after the company announced a multi-year electric vehicle charging station... 
Via Benzinga
Topics Electric Vehicles
Exposures Electric Vehicles
54 Biggest Movers From Yesterday
Gainers Longeveron Inc. (NASDAQ: LGVN) shares climbed 135.3% to close at $6.87 on Thursday. Longeveron said the FDA granted rare pediatric disease designation for the company... 
Via Benzinga
Exposures Product Safety
Mid-Afternoon Market Update: Dow Falls 75 Points; Dicerna Pharmaceuticals Shares Spike Higher
Toward the end of trading Thursday, the Dow traded down 0.21% to 35,855.96 while the NASDAQ rose 0.16% to 15,946.49. The S&P also rose, gaining 0.19% to 4,697.80. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
LGVN Stock Alert: The Huge FDA News Sending Longeveron to the Moon Today
Today, the FDA has smiled on Longeveron, with investors in LGVN stock seeing absolutely astronomical gains of more than 180% this morning. 
Via InvestorPlace
Exposures Product Safety
Mid-Day Market Update: Macy's Surges After Q3 Results; Amtech Systems Shares Plunge
Midway through trading Thursday, the Dow traded down 0.52% to 35,745.78 while the NASDAQ fell 0.22% to 15,886.57. The S&P also fell, dropping 0.16% to 4,681.24. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
44 Stocks Moving In Thursday's Mid-Day Session
Gainers Longeveron Inc. (NASDAQ: LGVN) jumped 157% to $7.51. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the... 
Via Benzinga
Exposures Product Safety
Why Are Longeveron Shares Skyrocketing On Thursday?
The FDA has granted Rare Pediatric Disease (RPD) designation for Longeveron Inc's (NASDAQ: LGVN) Lomecel-B for Hypoplastic Left Heart Syndrome (HLHS).... 
Via Benzinga
Exposures Product Safety
Mid-Morning Market Update: Markets Down; Kohl's Earnings Top Expectations
Following the market opening Thursday, the Dow traded down 0.70% to 35,678.02 while the NASDAQ fell 0.36% to 15,863.49. The S&P also fell, dropping 0.24% to 4,677.46. The U.S... 
Via Benzinga
Topics Stocks
Exposures US Equities
Earnings Scheduled For November 12, 2021
Companies Reporting Before The Bell • Zevia (NYSE:ZVIA) is estimated to report quarterly loss at $0.43 per share on revenue of $34.40 million. • Natura &Co... 
Via Benzinga
5 Cheap Stocks Set to Double This Month
This article is excerpted from Tom Yeung's Moonshot Investor newsletter. To make sure you don't miss any of Tom's potential 100x picks, subscribe to his 
Via InvestorPlace
3 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider... 
Via Benzinga
2 Penny Stocks Insiders Are Buying
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Longeveron (NASDAQ:LGVN) shares ... 
Via Benzinga
Longeveron Successfully Advancing its Cell-Based Therapy Studies in a Growing Industry Segment
Research and development of stem cell-based therapies, where a patient’s own cells, or those from a donor, are used to fight injury and disease, is one of the fastest... 
Via Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc... 
Via Benzinga
Longeveron Announces Potential Biomarker Correlating with Lomecel-B Bioactivity
Lomecel-B significantly decreased biomarker Tie-2 in Aging Frailty subjects at 270 days compared to placebo Significant, dose-dependent decrease in Tie-2 at Day 270 Oral... 
Via Benzinga
EXCLUSIVE: Longeveron Announces Biomarker Analysis Data From Mid-Stage Study Of Anti-Aging Cell Therapy Candidate
Longeveron Inc. (NASDAQ: LGVN) announced Wednesday positive biomarker analysis data from the mid-stage study of its lead cell therapy candidate in aging frailty subjects. What... 
Via Benzinga
Heart Hope: Announcing the Encouraging Results of a Cell-Therapy Clinical Study by Longeveron
Photo by jesse orrico on Unsplash Researchers in the medical field are constantly working to create medicines to prevent and cure diseases. The development of the multiple COVID-... 
Via Benzinga
Longeveron Announces Final Results of Phase 1 Clinical Study of Lomecel-B Injection in Hypoplastic Left Heart Syndrome Patients
--Study meets primary safety endpoint: no major adverse cardiac events (MACE), nor any treatment-related infections during the first month post-treatment. --Secondary... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Soligenix (NASDAQ:SNGX) stock increased by 22.85% to $1.29 during Thursday's pre-market session. The company's market cap stands at $51.7 million. Cardiff... 
Via Benzinga
EXCLUSIVE: Longeveron's Lomecel-B Cell Therapy Meets Primary Safety Endpoint In Phase 1 Rare Congenital Heart Disease Study
Longeveron Inc. (NASDAQ: LGVN), a cell therapy company developing therapies for age-related and life-threatening conditions, reported Thursday final results from a Phase 1 study... 
Via Benzinga
The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23) AbbVie Inc. (NYSE: ABBV) (... 
Via Benzinga
Exposures Product Safety
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.